FDA Inspection 792844 — Kowa Pharmaceuticals America
The FDA completed an inspection of Kowa Pharmaceuticals America on July 26, 2012 in Montgomery, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montgomery, AL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)